Search research articles
Contact Us
Filters
Showing results (11-20 of 55) with videos related to
Page
of 6
Sort By:
Blood
|
July 1, 1993
Adhesion to high endothelial venules: a model for dissemination mechanisms in non-Hodgkin's lymphoma
R Stauder, S Hamader, B Fasching, et al.
Cancer Surveys
|
January 1, 1995
Are CD44 variant isoforms involved in human tumour progression?
U Günthert, R Stauder, B Mayer, et al.
Histopathology
|
June 1, 1991
Bone marrow diagnosis in lymphoproliferative disorders: comparison of results obtained from conventional histomorphology and immunohistology
J Thaler, O Dietze, H Denz, et al.
The Journal of Cell Biology
|
January 1, 1994
Expression and modulation of CD44 variant isoforms in humans
C R Mackay, H J Terpe, R Stauder, et al.
Journal of Hematotherapy & Stem Cell Research
|
August 28, 2001
Optimal timing for the collection and in vitro expansion of cytotoxic CD56(+) lymphocytes from patients undergoing autologous peripheral blood stem cell transplantation
J Clausen, A L Petzer, B Vergeiner, et al.
Leukemia Research
|
June 22, 1999
Expression of LFA-1 identifies different prognostic subgroups in patients with advanced follicle center lymphoma (FCL)
O E Bechter, W Eisterer, S Dirnhofer, et al.
Leukemia
|
November 21, 1998
CD44 isoforms distinguish between bone marrow plasma cells from normal individuals and patients with multiple myeloma at different stages of disease
M van Driel, U Günthert, R Stauder, et al.
Immunology Letters
|
February 1, 1987
Involvement of complement in B-cell, T-cell and monocyte/macrophage activation
M P Dierich, A Erdei, H Huemer, et al.
Immunology
|
January 1, 1988
Structural and functional analysis of CR2/EBV receptor by means of monoclonal antibodies and limited tryptic digestion
A L Petzer, T F Schulz, R Stauder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2015
Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary
V A Morrison, P Hamlin, P Soubeyran, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 55) with videos related to
Sort By:
Page
of 6
Blood
|
July 1, 1993
Adhesion to high endothelial venules: a model for dissemination mechanisms in non-Hodgkin's lymphoma
R Stauder, S Hamader, B Fasching, et al.
Cancer Surveys
|
January 1, 1995
Are CD44 variant isoforms involved in human tumour progression?
U Günthert, R Stauder, B Mayer, et al.
Histopathology
|
June 1, 1991
Bone marrow diagnosis in lymphoproliferative disorders: comparison of results obtained from conventional histomorphology and immunohistology
J Thaler, O Dietze, H Denz, et al.
The Journal of Cell Biology
|
January 1, 1994
Expression and modulation of CD44 variant isoforms in humans
C R Mackay, H J Terpe, R Stauder, et al.
Journal of Hematotherapy & Stem Cell Research
|
August 28, 2001
Optimal timing for the collection and in vitro expansion of cytotoxic CD56(+) lymphocytes from patients undergoing autologous peripheral blood stem cell transplantation
J Clausen, A L Petzer, B Vergeiner, et al.
Leukemia Research
|
June 22, 1999
Expression of LFA-1 identifies different prognostic subgroups in patients with advanced follicle center lymphoma (FCL)
O E Bechter, W Eisterer, S Dirnhofer, et al.
Leukemia
|
November 21, 1998
CD44 isoforms distinguish between bone marrow plasma cells from normal individuals and patients with multiple myeloma at different stages of disease
M van Driel, U Günthert, R Stauder, et al.
Immunology Letters
|
February 1, 1987
Involvement of complement in B-cell, T-cell and monocyte/macrophage activation
M P Dierich, A Erdei, H Huemer, et al.
Immunology
|
January 1, 1988
Structural and functional analysis of CR2/EBV receptor by means of monoclonal antibodies and limited tryptic digestion
A L Petzer, T F Schulz, R Stauder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2015
Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary
V A Morrison, P Hamlin, P Soubeyran, et al.
Page
of 6